Jelle Barentsz, MD, presented “The Use of MRI to Determine the Target for Focal Therapy” for the Grand Rounds in Urology audience during a break at the 30th Annual International Prostate Cancer Update in January, 2020.
How to cite: Barentsz, Jelle. “The Use of MRI to Determine the Target for Focal Therapy” January, 2020. Accessed May 2022. https://grandroundsinurology.com/the-use-of-mri-to-determine-the-target-for-focal-therapy/
The Use of MRI to Determine the Target for Focal Therapy – Summary:
Jelle Barentsz, MD, PhD, Professor of Radiology at the Nijmegen Medical Center of Radboud University in Nijmegen, The Netherlands, discusses the use of MRI to determine targets for focal therapy in prostate cancer patients with E. David Crawford, MD, Professor of Urology at the University of California, San Diego. Dr. Barentsz emphasizes that practitioners require appropriate experience to use MRI in this way, suggesting that a lack of base-level knowledge has prevented many doctors in the United States from making effective use of this technique. He notes, however, that focal therapy has revolutionized breast cancer treatment and has the potential to transform prostate cancer care as well. Dr. Crawford concurs and shares his largely positive experiences with MRI-targeted focal therapy.
About The 30th Annual International Prostate Cancer Update:
The International Prostate Cancer Update (IPCU), founded in 1990, is a multi-day CME conference focused on prostate cancer treatment updates with expert, international faculty. It is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer. Dr. Barentsz & Dr. Crawford discussed this topic during a break at the 30th iteration of the meeting in January 2020.
Other parts of this interview include:
For further educational activities from this conference, visit our collection page.